• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • View Item
  •   LillOA Home
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Factual understanding of randomized clinical ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1200/JCO.2005.02.8100
PMID :
19760365
Permalink :
http://hdl.handle.net/20.500.12210/29211
Title :
Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients
Author(s) :
Leroy, Tanguy [Auteur]
Christophe, Veronique [Auteur] orcid refId
Penel, Nicolas [Auteur] refId
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Antoine, Pascal [Auteur] refId
Clisant, Stéphanie [Auteur]
Journal title :
Investigational New Drugs
Abbreviated title :
Invest New Drugs
Volume number :
24
Pages :
891-705
Publisher :
Springer Verlag
Publication date :
2011
ISSN :
0167-6997
Keyword(s) :
Randomized clinical trial
Informed consent process
Cancer
Factual understanding
Information
HAL domain(s) :
Sciences de l'Homme et Société/Psychologie
English abstract : [en]
Objective Several reports have shown that despite the informed consent process, enrolled patients misunderstand the modalities and goals of randomized clinical trials (RCTs). We believe that this may be linked to a priori ...
Show more >
Objective Several reports have shown that despite the informed consent process, enrolled patients misunderstand the modalities and goals of randomized clinical trials (RCTs). We believe that this may be linked to a priori misconceptions in the main population. The purpose of this study is to compare the knowledge about cancer RCTs in enrolled participants (cases) versus patients treated under cancer standard care who have never taken part in RCTs (controls). Methods We submitted a validated questionnaire (ICEC-R) to both populations to explore their knowledge about RCTs. A total of 75 cases and 107 controls were included. Results Globally, the cases' knowledge was significantly better, especially about (i) the randomization process, (ii) the uncertain potential benefits, and (iii) the right to withdraw consent. Both populations presented the lowest scores for items exploring the randomization process and uncertain treatment benefits. Conclusion Enrolled patients' comprehension of the goals and means of RCTs is actually better than controls'. Nevertheless, additional efforts should be made to enhance information about clinical research to patients as well as to the main population. Practice Implications Having better knowledge about patients' difficulties in understanding RCTs would allow physicians to adjust the information they give and then to enhance patients' well-being.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
CNRS
Université de Lille
Collections :
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Submission date :
2020-06-08T14:10:26Z
Université de Lille

Mentions légales
Université de Lille © 2017